The Conolidine Diaries
These effects, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 aid the principle of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders.Renal parenchymal disease is a group of condition